re: glaxo plans bird flu boost..gsk wakes up final when you think gsk have spent approx.$750 million to get relenza to market, they now have the demand to push relenza that was not there in 2000.all biota has to do is wait for there 7% cut.and get there pipeline of new drugs into clinical trials,is there any upside here???????????????????????????
glaxo plans bird flu boost, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)